3.3(top 10%)
impact factor
2.0K(top 10%)
papers
14.1K(top 20%)
citations
47(top 20%)
h-index
3.7(top 10%)
extended IF
2.1K
all documents
15.0K
doc citations
81(top 10%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | Cancer incidence and mortality in China, 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 809 |
2 | Cervical cancer: Epidemiology, risk factors and screening | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 320 |
3 | Liver cancer incidence and mortality in China: Temporal trends and projections to 2030 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 275 |
4 | Cancer incidence and mortality in China in 2013: an analysis based on urbanization level | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 226 |
5 | Updates on larynx cancer epidemiology | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 189 |
6 | Gastric cancer: Epidemiology, risk factors and prevention strategies | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 176 |
7 | Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 172 |
8 | Incidence and mortality of stomach cancer in China, 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 168 |
9 | Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 160 |
10 | Antioxidant enzymes and cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2010 | 156 |
11 | Cancer burden and trends in China: A review and comparison with Japan and South Korea | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 146 |
12 | Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 146 |
13 | Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 140 |
14 | Esophageal cancer: Epidemiology, risk factors and screening | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 134 |
15 | Validation and reliability of distress thermometer in Chinese cancer patients | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 112 |
16 | Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 110 |
17 | Epidemiology and risk factors of colorectal cancer in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2020 | 101 |
18 | Overproduction of reactive oxygen species – obligatory or not for induction of apoptosis by anticancer drugs | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 95 |
19 | Cancer incidence and mortality in China, 2007 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 94 |
20 | Report of incidence and mortality in China Cancer Registries, 2008 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2012 | 85 |
21 | Screening for gastric cancer in China: Advances, challenges and visions | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 80 |
22 | Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 79 |
23 | High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 74 |
24 | Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 73 |
25 | Burden of liver cancer: From epidemiology to prevention | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2022 | 72 |
26 | Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 71 |
27 | Colorectal cancer burden and trends: Comparison between China and major burden countries in the world | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 68 |
28 | Incidence and mortality of laryngeal cancer in China, 2008−2012 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 67 |
29 | Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 66 |
30 | Expenditure of hospital care on cancer in China, from 2011 to 2015 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 66 |
31 | Tumor immunotherapy: New aspects of natural killer cells | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 61 |
32 | Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 61 |
33 | Incidence and mortality of thyroid cancer in China, 2008−2012 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 61 |
34 | Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 59 |
35 | Induction of the apoptosis of cancer cell by sonodynamic therapy: a review | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2013 | 58 |
36 | Incidence and mortality of cervical cancer in China, 2013 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2017 | 58 |
37 | Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 58 |
38 | Immune signature profiling identified prognostic factors for gastric cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 58 |
39 | Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 58 |
40 | Cancer incidence and mortality in China, 2006 | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2011 | 57 |
41 | Mn-based cGAS-STING activation for tumor therapy | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2023 | 56 |
42 | Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 55 |
43 | Chemotherapy and molecular targeting therapy for recurrent cervical cancer | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 53 |
44 | Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 53 |
45 | Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2018 | 52 |
46 | Boron neutron capture therapy for malignant melanoma: first clinical case report in China | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 52 |
47 | Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2016 | 51 |
48 | Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2019 | 49 |
49 | HCA520, a novel tumor associated antigen, involved in cell proliferation and apoptosis | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2003 | 48 |
50 | Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version) | Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research | 2021 | 48 |